106-120 of 937
The Cost of Progress: Examining Barriers to ATTR-CM Care
On the Frontlines of ATTR-CMThe Cost of Progress: Examining Barriers to ATTR-CM Care
Charles Turck, PharmD, BCPS, BCCCP
Michelle Kittleson, MD, PhD
Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
Heart MattersUnderstanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart MattersDiagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart MattersATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Ryan Quigley
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
On the Frontlines of ATTR-CMVutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
Ryan Quigley
Farooq Hameed Sheikh, MD
- advertisement
Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Heart MattersSex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Gender Bias and Heart Health: Improving Cardiovascular Care for Women
Heart MattersGender Bias and Heart Health: Improving Cardiovascular Care for Women
STORM-PE: Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
Clinician's RoundtableSTORM-PE: Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
Effect of Vericiguat on Heart Failure Hospitalization Events in Ambulatory Patients With HFrEF: VICTOR Trial Prespecified Analysis
CardiologyEffect of Vericiguat on Heart Failure Hospitalization Events in Ambulatory Patients With HFrEF: VICTOR Trial Prespecified Analysis
Javed Butler, MD, MPH, MBA
VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
CardiologyVICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
Carolyn Lam, MD
VICTOR Prespecified Analysis Results: Vericiguat Effects on Mortality in Ambulatory Patients With HFrEF
CardiologyVICTOR Prespecified Analysis Results: Vericiguat Effects on Mortality in Ambulatory Patients With HFrEF
Stephen Greene
- advertisement
VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF
CardiologyVICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF
Justin Ezekowitz, MD, MBBCh, MSc
Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Heart MattersManaging Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Heart MattersManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
